What's breaking now, across thousands of outlets.
Plus news about Alchemist Capital, Newron Pharmaceuticals, Life Biosciences, Onyx Bio and Tecentriq. City Therapeutics charts $158M IPO: The RNAi startup, from former Alnylam Pharmaceuticals executives, is looking to sell 9.72 million shares at $17 ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Muthoot Microfin plans to launch consumer durable loans and expand digital lending as it targets ₹30,000 crore in assets under management by 2030
The NBA Commissioner further called it "odd behavior" to have contracts related to whether a coach may be fired or not.
The Canadian dollar sank to its weakest level since April 2025 after a softer-than-expected reading of the nation’s labor market reduced the odds of an interest-rate increase by the Bank of Canada.
NY AG Letitia James secured up to $35M from ex-Celsius CEO Alex Mashinsky and a permanent ban from the securities and crypto industries.
